Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension

NCT01847716 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01847716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01847716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Terminated
Start date
October 31, 2013
Completion date
August 31, 2016
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle weakness, pulmonary arterial hypertension